| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |